Therefore, we further investigated MMP1, IL-8, and caspase-3 in possible IPA and CAPA patient sera to evaluate their potential as discriminative markers for different clinical manifestations of aspergillosis. This evidence concerns the gene CASP3 and episodic ataxia type 2.